BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19934487)

  • 1. Performance assessment of the BEBIG MultiSource high dose rate brachytherapy treatment unit.
    Palmer A; Mzenda B
    Phys Med Biol; 2009 Dec; 54(24):7417-34. PubMed ID: 19934487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source.
    Granero D; Pérez-Calatayud J; Ballester F
    Radiother Oncol; 2005 Jul; 76(1):79-85. PubMed ID: 16019091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
    Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a TLD mailed system for remote dosimetry audit for (192)Ir HDR and PDR sources.
    Roué A; Venselaar JL; Ferreira IH; Bridier A; Van Dam J
    Radiother Oncol; 2007 Apr; 83(1):86-93. PubMed ID: 17368842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry.
    Calcina CS; de Almeida A; Rocha JR; Abrego FC; Baffa O
    Phys Med Biol; 2005 Mar; 50(6):1109-17. PubMed ID: 15798311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative three-dimensional dose attenuation analysis around Fletcher-Suit-Delclos due to stainless steel tube for high-dose-rate brachytherapy by Monte Carlo calculations.
    Parsai EI; Zhang Z; Feldmeier JJ
    Brachytherapy; 2009; 8(3):318-23. PubMed ID: 19217355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent screen for high-dose-rate (HDR) brachytherapy quality assurance.
    Lightstone AW
    Med Dosim; 2005; 30(3):143-4. PubMed ID: 16112464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of transit dose profile for a (192)Ir HDR source.
    Fonseca GP; Rubo RA; Minamisawa RA; dos Santos GR; Antunes PC; Yoriyaz H
    Med Phys; 2013 May; 40(5):051717. PubMed ID: 23635265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transit dose contributions to intracavitary and interstitial PDR brachytherapy treatments.
    Menon GV; Carlone MC; Sloboda RS
    Phys Med Biol; 2008 Jul; 53(13):3447-62. PubMed ID: 18547912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.
    Awunor O; Berger D; Kirisits C
    Med Phys; 2015 Aug; 42(8):4472-83. PubMed ID: 26233177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators.
    Beddar AS; Krishnan S; Briere TM; Wang X; Delclos ME; Ballo MT; Das P; Gould S; Horton JL; Crane CH
    Radiother Oncol; 2006 Feb; 78(2):207-12. PubMed ID: 16376445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a phantom for the quality control of high dose rate 192Ir source used in brachytherapy.
    Ochoa R; Gómez F; Ferreira IH; Gutt F; de Almeida CE
    Radiother Oncol; 2007 Feb; 82(2):222-8. PubMed ID: 17267060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving patient-specific dosimetry for intravascular brachytherapy.
    Li XA; O'Neill M; Suntharalingam M
    Brachytherapy; 2005; 4(4):291-7. PubMed ID: 16344260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of high dose rate brachytherapy dose distributions with EBT3 Gafchromic film quality control techniques.
    Palmer AL; Nisbet A; Bradley D
    Phys Med Biol; 2013 Feb; 58(3):497-511. PubMed ID: 23306148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel system for commissioning brachytherapy applicators: example of a ring applicator.
    Fonseca GP; Van den Bosch MR; Voncken R; Podesta M; Verhaegen F
    Phys Med Biol; 2017 Oct; 62(21):8360-8375. PubMed ID: 28914613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dosimetric study of Leipzig applicators.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E; Soriano A; Crispín V
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):579-84. PubMed ID: 15890603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion.
    Kertzscher G; Andersen CE; Siebert FA; Nielsen SK; Lindegaard JC; Tanderup K
    Radiother Oncol; 2011 Sep; 100(3):456-62. PubMed ID: 21963285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surface curvature on dose delivery in intraoperative high-dose-rate brachytherapy.
    Oh M; Wang Z; Malhotra HK; Jaggernauth W; Podgorsak MB
    Med Dosim; 2009; 34(1):63-74. PubMed ID: 19181258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.